Drug profile · INN
sonrotoclax
BEQALZI
sonrotoclax (BEQALZI) is an FDA-listed pharmaceutical active ingredient. Associated with BEONE MEDICINES AUS PTY LTD. Route of administration: oral. Current US regulatory status: approved.
Drug details — sonrotoclax
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 6
- Data quality
- 0.89
Quick answer
sonrotoclax (BEQALZI) is an FDA-listed pharmaceutical active ingredient. Associated with BEONE MEDICINES AUS PTY LTD. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is sonrotoclax?
sonrotoclax (BEQALZI) is an FDA-listed pharmaceutical active ingredient. Associated with BEONE MEDICINES AUS PTY LTD. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sonrotoclax?
BEQALZI is a marketed brand name for sonrotoclax. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sonrotoclax?
sonrotoclax has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.